Quality and consistency of clinical practice guidelines for treating children with COVID-19

Qinyuan Li1, Qi Zhou2,3, Yangqin Xun3

  • 1Department of Respiratory Medicine Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.

Insights

Clinical practice guidelines for pediatric Coronavirus Disease 2019 (COVID-19) treatment show low quality and inconsistent recommendations. Limited evidence from children hinders effective care guidance.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Practice Guidelines
  • Evidence-Based Medicine

Background:

  • The Coronavirus Disease 2019 (COVID-19) pandemic significantly impacts children's health.
  • Numerous clinical practice guidelines (CPGs) exist for pediatric COVID-19 treatment.
  • The quality and consistency of these CPGs are largely unknown.

Purpose of the Study:

  • To systematically review and evaluate the quality of existing CPGs for managing COVID-19 in children.
  • To assess the methodological rigor and reporting completeness of pediatric COVID-19 CPGs.
  • To analyze the consistency of treatment recommendations across guidelines.

Main Methods:

  • Systematic literature search of databases (Medline, Embase) and guideline repositories.
  • Evaluation of guideline quality using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool.
  • Assessment of reporting completeness using the Reporting Items for practice Guidelines in HealThcare (RIGHT) checklist.
  • Analysis of recommendation consistency and supporting evidence.

Main Results:

  • Twenty pediatric COVID-19 CPGs were included.
  • Methodological quality was predominantly low (95%), with only one moderate.
  • Reporting quality was mostly moderate (60%), with one high-quality guideline.
  • Significant inconsistencies were found in recommendations for treatments like remdesivir, interferon, glucocorticoids, and IVIG.
  • None of the guidelines cited clinical trials involving pediatric COVID-19 patients.

Conclusions:

  • Pediatric COVID-19 CPGs exhibit suboptimal methodological and reporting quality.
  • Treatment recommendations vary widely among guidelines, indicating a lack of consensus.
  • The evidence base derived from pediatric COVID-19 studies used in these guidelines is notably limited.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
59
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
855
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
881
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K